Adeno-associated Viral Vector Therapies

All categories
DBCAT005646Therapeutic category

This category contains approved and investigational gene therapies utilizing adeno-associated virus (AAV) vectors. Gene therapies that use AAV vectors are denoted as such in standard gene therapy nomenclature by the infix -parvo- in the second... A DrugBank category of 55 drugs. 12 of them are approved.

Also known as
AAV vector · Adeno-associated Virus Vector
Drugs

and 30 more with a free account

What you can answer from here — as of September 15, 2022

55DrugsEach linked to its full drug card
Sign in
11Drug targetsEvery drug–target pair in the class, with bond type
Sign in
195Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
9Routes of administrationHow the drugs in this class are given
Sign in
1ReferenceSupporting the category definition
Sign in

Which targets do Adeno-associated Viral Vector Therapies share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In